UCLA Researchers & Innovators
Industry & Investors
News & Events
About
Concierge
Search Results - tumor+microenvironment
2
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Combination Cancer Therapy Methods and Agents (UCLA Case No. 2024-084)
UCLA researchers from the Department of Medicine, Pathology, & Laboratory Medicine and Molecular & Medical Pharmacology have identified a novel cell-based therapy that leads to enhanced immunotherapy efficacy and overcomes treatment resistance to immune checkpoint blockade in non-small cell lung cancer. BACKGROUND: Non-small cell lung cancer...
Published: 11/4/2024
|
Inventor(s):
Bin Liu
,
Steven Dubinett
Keywords(s):
anti-tumor immunity
,
cell-based therapy
,
Immune checkpoint blockade
,
Immunotherapy
,
non-small cell lung cancer
,
treatment resistance
,
Tumor microenvironment
,
Vaccines
Category(s):
Therapeutics > Oncology
,
Therapeutics > Immunology And Immunotherapy
,
Therapeutics > Respiratory And Pulmonary
Engineered T Cells Capable of Simultaneous Tumor Targeting and Alteration of
Tumor Microenvironment
Through Vasculature Normalization (UCLA Case No. 2023-264)
UCLA researchers in the Department of Microbiology, Immunology and Molecular Genetics have built a series of chimeric antigen receptor (CAR)-T cells that target different antigens and secrete different anti-angiogenic proteins. Additionally, researchers also constructed bispecific CARs that respond to tumor antigen and pro-angiogenic molecules. BACKGROUND:...
Published: 6/27/2024
|
Inventor(s):
Yvonne Chen
Keywords(s):
Cancer
,
Cancer Immunotherapy
,
CAR-T cell therapy
,
immunosuppression
,
Immunosuppressive Drug
,
Immunotherapy
,
solid tumors
,
Tumor microenvironment
,
tumor vasculature
,
VEGF
Category(s):
Therapeutics > Oncology